Rigel Pharmaceuticals RIGL Accrued liabilities
Accrued liabilities at other companies
Other financials
Where this comes from
Reported directly by Rigel Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:IncreaseDecreaseInOtherAccruedLiabilities.
The official record: Rigel Pharmaceuticals’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →
Ask your AI about Rigel Pharmaceuticals's accrued liabilities.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is Rigel Pharmaceuticals's accrued liabilities?
- Rigel Pharmaceuticals (RIGL) reported accrued liabilities of -$1.79M in Q1 2026.
- How has Rigel Pharmaceuticals's accrued liabilities changed year-over-year?
- Rigel Pharmaceuticals's accrued liabilities increased by 39.3% year-over-year, from -$2.95M to -$1.79M.